Interleukin-1beta reduces galactose transport in intestinal epithelial cells in a NF-kB and protein kinase C-dependent manner

Veterinary Immunology and Immunopathology

Volumn 155, Issue 3, 2013, Pages 171-181

  Viñuales, Carmen ^a   Gascón, Sonia ^a,b   Barranquero, Cristina ^a,b   Osada, Jesús ^a,b   Rodríguez Yoldi, Ma Jesús ^a,b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Galactose; Gut; IL 1 ; Kinases; NF kB

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GALACTOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SODIUM GLUCOSE COTRANSPORTER 1;

ACTIVE TRANSPORT; ANIMAL CELL; APICAL MEMBRANE; ARTICLE; BRUSH BORDER; CELL STRAIN CACO 2; HEXOSE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; INTRACELLULAR SIGNALING; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SUGAR TRANSPORT;

ORYCTOLAGUS CUNICULUS;

GALACTOSE; GUT; IL-1Β; KINASES; NF-KB;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GALACTOSE; HUMANS; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MALE; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PROTEIN KINASE C; RABBITS; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 84883055863     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2013.06.016     Document Type: Article

References (76)

1. Abad B., Mesonero J.E., Salvador M.T., García-Herrera J., Rodríguez-Yoldi M.J. The administration of lipopolysaccharide, in vivo, induces alteration in L-leucine intestinal absorption. Life Sci. 2001, 70:615-618.
2. Abad B., Mesonero J.E., Salvador M.T., García-Herrera J., Rodríguez-Yoldi M.J. Cellular mechanism underlying LPS-induced inhibition of in vitro l-leucine transport across rabbit jejunum. J. Endotoxin Res. 2002, 8:127-133.
3. Abad B., Mesonero J.E., Salvador M.T., García-Herrera J., Rodríguez-Yoldi M.J. Tumor necrosis factor-α mediates inhibitory effect of lipopolysaccharide on l-leucine intestinal uptake. Dig. Dis. Sci. 2002, 46:1316-1322.
4. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262(12):5592-5595.
5. Al-Sadi R.M., Ma T.Y. IL-1β causes an increase in intestinal epithelial tight junction permeability. J. Immunol. 2007, 178:4641-4649.
6. Amador P., García-Herrera J., Marca M.C., de la Osada J., Acín S., Navarro M.A., Salvador M.T., Lostao M.P., Rodriguez-Yoldi M.J. Intestinal d-galactose transport in an endotoxemia model in the rabbit. J. Membr. Biol. 2007, 215:125-133.
7. Amador P., García-Herrera J., Marca M.C., de la Osada J., Acín S., Navarro M.A., Salvador M.T., Lostao M.P., Rodriguez-Yoldi M.J. Inhibitory effect of TNF-α on the intestinal absorption of galactose. J. Cell. Biochem. 2007, 101:99-111.
8. Amador P., Marca M.C., García-Herrera J., Lostao M.P., Gillén N., de la Osada J., Rodriguez-Yoldi M.J. Lipopolysaccharide induces inhibition of galactose intestinal transport in rabbits in vitro. Cell. Physiol. Biochem. 2008, 22:715-724.
9. +-d-glucose cotransporter SGLT1 in rat organs with an improved antibody. Am. J. Physiol. Cell. Physiol. 2008, 295:C475-C489.
10. Bértolo C., Barrenetxe J., Barber A., Lostao M.P. Cytokine effect on intestinal galactose absorption. J. Physiol. Biochem. 2002, 58(1):61-62.
11. Bonizzi G., Karin M. The two NF-kB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25(6):280-288.
12. Bowie A., O'Neill L.A.J. The interleukin-1 receptor Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 2000, 67:508-514.
13. Casini-Raggi V., Kam L., Chong Y.J., Fiocchi C., Pizarro T.T., Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J. Immunol. 1995, 154(5):2434-2440.
14. Chang E.B., Musch M.W., Mayer L. Interleukin 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology 1990, 98:1518-1524.
15. Cheng H.C., Kemp B.E., Pearson R.B., Smithm A.J., Misconi L., Van Patten S.M., Walsh D.A. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J. Biol. Chem. 1986, 261:989-992.
16. Comelli E.M., Simmering R., Faure M., Donnicola D., Mansourian R., Rochat F., Corthesy-Theulaz I., Cherbut C. Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota. Genomics 2008, 91:70-77.
17. Cominelli F., Nast C.C., Llerena R., Dinarello C.A., Zipser R.D. Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins. J. Clin. Invest. 1990, 85(2):582-586.
18. Cominelli F., Bortolami M., Pizarro T.T., Monsacchi L., Ferretti M., Brewer M.T., Eisenberg S.P., Ng R.K. Rabbit Interleukin-1 receptor antagonist. Cloning, expression, functional characterization, and regulation during intestinal inflammation. J. Biol. Chem. 1994, 269(9):6962-6971.
19. Craig R., Larkin A., Mingo A.M., Thuerauf D.J., Andrews C., McDonough P.M., Glembotski C.C. p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. J. Biol. Chem. 2000, 275(31):23814-23824.
20. Cui X.L., Schlesier A.M., Fisher E.L., Cerqueira C., Ferraris R.P. Fructose-induced increases in neonatal rat intestinal fructose transport involve the PI3-kinase/Akt signalling pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 288:G1310-G1320.
21. +-dependent glucose transport during differentiation of an intestinal epithelial cell clone is regulated by PKC. J. Biol. Chem. 1995, 279:12536-12541.
22. Dinarello C.A. Interleukin-1. Cytokine Growth Factor Rev. 1997, 8(4):253-265.
23. Dinarello C.A. Interleukin-1β. Crit. Care Med. 2005, 33(12):S460-S462.
24. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
25. Elewaut D., DiDonato J.A., Kim J.M., Truong F., Eckmann L., Kagnoff M.F. NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 1999, 163(3):1457-1466.
26. Eskan M.A., Benakanakere M.R., Rose B.G., Zhang P., Zhao J., Stathopoulou P., Fujioka O., Kinane D.F. Interleukin-1β modulates proinflammatory cytokine production in human epithelial cells. Infect. Immun. 2008, 76(5):2080-2089.
27. Field M. Ion transport in rabbit ileal mucosa, II. Effects of cyclic 3', 5'-AMP. Am. J. Physiol. 1971, 221:992-997.
28. Freshney N.W., Rawlinson L., Guesdon F., Jones E., Cowley S., Hsuan J., Saklatvala J. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 1994, 78(6):1039-1049.
29. Frobose H., Ronn S.G., Heding P.E., Mendoza H., Cohen P., Mandrup-Poulsen T., Billestrup N. Suppressor of cytokine signalling-3 inhibits Interleukin-1 signaling by targeting the TRAF-6/TAK1 Complex. Mol. Endocrinol. 2006, 20(7):1587-1596.
30. García-Barrios A., Guillén N., Osada J., Vazquez C.M., Miguel-Carrasco J.L., Rodríguez-Yoldi M.J. Nitric oxide involved in the IL-1-induced inhibition of fructose intestinal transport. J. Cell. Biochem. 2010, 111:1321-1329.
31. García-Herrera J., Abad B., Rodríguez-Yoldi M.J. Effect of lipopolysaccharide on d-fructose transport across rabbit jejunum. Inflamm. Res. 2003, 52:177-184.
32. García-Herrera J., Navarro M.A., Marca M.C., De la Osada J., Rodríguez-Yoldi M.J. The effect of tumor necrosis factor-α on d-fructose intestinal transport in rabbits. Cytokine 2004, 25:21-30.
33. García-Herrera J., Marca M.C., Brot-Laroche E., Guillén N., Acín S., Navarro M.A., Osada J., Rodriguez-Yoldi M.J. Protein kinases, TNF-α, and proteasome contribute in the inhibition of fructose intestinal transport by sepsis in vivo. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G155-G164.
34. +-d-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012, 61(1):187-196.
35. Gouyon F., Onesto C., Dalet V., Pages G., Leturque A., Brot-Laroche E. Fructose modulates GLUT5 mRNA stability in differentiated Caco-2 cells: role of cAMP-signalling pathway and PABP (polyadenyllated-binding protein)-interacting protein (paip)2. Biochem. J. 2003, 375:167-174.
36. Gronich J., Konieczkowski M., Gelb M.H., Nemenoff R.A., Sedor J.R. Interleukin-1α causes a rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 1994, 93:1224-1233.
37. Groschwitz K.R., Hogan S.P. Intestinal barrier function: molecular regulation and disease pathogenesis. J. Allergy Clin. Immunol. 2009, 124(1):3-20.
38. Haddad J.J., Lauterbach R., Saadé N.E., Safieh-Garabedian B., Land S.C. Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium. Biochem. J. 2001, 355(1):29-38.
39. Haddad J.J., Fahlman C.S. Nuclear Factor-kB-independent regulation of lipopolysaccharide-mediated interleukin-6 biosynthesis. Biochem. Biophys. Res. Commun. 2002, 291:1045-1051.
40. Haddad J.J., Land S.C. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br. J. Pharmacol. 2002, 135(2):520-536.
41. Haddad J.J. The involvement of l-gamma-glutamyl-l-cysteinyl-glycine (glutathione/GSH) in the mechanism of redox signaling mediating MAPK(p38)-dependent regulation of pro-inflammatory cytokine production. Biochem. Pharmacol. 2002, 63(2):305-320.
42. Hardin J., Kroeker K., Chung B., Gall D.G. Effect of proinflammatory interleukins on jejunal nutrient transport. Gut 2000, 47:184-191.
43. + transport by carbachol across the rat distal colon. Eur. J. Pharmacol. 1999, 377:75-80.
44. Helliwell P.A., Richardson M., Affleck J., Kellett G.L. Regulation of GLUT5, GLUT2 and intestinal brush-border fructose absorption by the extracellular signal-regulated kinase, p38 mitogen-activated kinase and phosphatidylinositol 3-kinase intracellular signalling pathways. Implications for adaptation to diabetes. Biochem. J. 2000, 350:163-169.
45. Helliwell P.A., Rumsby M.G., Kellett G.L. Intestinal sugar absorption is regulated by phosphorylation and turnover of protein kinase C βII mediated by phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent pathways. J. Biol. Chem. 2003, 278(31):28644-28650.
46. Herlaar E., Brown Z. p38 MAPK signalling cascades in inflammatory disease. Mol. Med. Today 1999, 5(10):439-447.
47. Herrmann J., Schröder B., Klinger S., Thorenz A., Werner A.C., Abel H., Breves G. Segmental diversity of electrogenic glucose transport characteristics in the small intestines of weaned pigs. Comp. Biochem. Physiol. A 2012, 163:161-169.
48. Isaacs K.L., Sartor R.B., Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mocosa detected by polymerase chain reaction amplification. Gastroenterology 1992, 103:1587-1595.
49. 14C] 3-o-methylglucose in the rat. Life Sci. 1998, 63(21):1913-1919.
50. Kyriakis J.M., Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81:807-869.
51. Lewis S.A., Berg J.R., Kleine T.J. Modulation of epithelial permeability by extracellular macromolecules. Physiol. Rev. 1995, 75:561-589.
52. Ligunsky M., Simon P.L., Karmeli F., Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990, 31:686-689.
53. Lin Y.Z., Yao S.Y., Veach R.A., Torgerson T.R., Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 1995, 270(24):14255-14258.
54. Liu Z., Shi C., Yang J., Zhang P., Ma Y., Wang F., Qin H. Molecular regulation of the intestinal epithelial barrier: implication in human diseases. Front. Biosci. 2011, 16:2903-2909.
55. Matsushima K., Kobayashi Y., Copeland T.D., Akahoshi T., Oppenheim J.J. Phosphorylation of a cytosolic 65-kDa protein induced by interleukin 1 in glucocorticoid pretreated normal human peripheral blood mononuclear leukocytes. J. Immunol. 1987, 139(10):3367-3374.
56. McKay D.M., Baird A.W. Cytokine regulation of epithelial permeability and ion transport. Gut 1999, 44:283-289.
57. McKay D.M., Watson J.L., Wang A., Caldwell J., Prescott D., Ceponis P.M., Di Leo V., Lu J. Phosphatidylinositol 3-kinase is a critical mediator of interferon-γ-induced increases in enteric epithelial permeability. J. Pharmacol. Exp. Ther. 2007, 320:1013-1022.
58. Mercurio F., Manning A.M. Multiple signals converging on NF-kappaB. Curr. Opin. Chem. Biol. 1999, 11(2):226-232.
59. Mesonero J.E., Matosin M., Cambier D., Rodríguez-Yoldi M.J., Brot-Laroche E. Sugar-dependent expresión of the fructose transporter GLUT5 in Caco-2 cells. Biochem. J. 1995, 312:757-762.
60. Miller A.J., Hopkins S.J., Luheshi G.N. Sites of action of IL-1 in the development of fever and cytokine responses to tissue inflammation in the rat. Br. J. Pharmacol. 1997, 120:1274-1279.
61. Mortola E., Larsen A. Infección por el virus de la lengua azul: activación de señales celulares que inducen apoptosis. Rev. Argent. Microbiol. 2009, 41:134-140.
62. Muegge K., Vila M., Gusella G.L., Musso T., Herrlich P., Stein B., Durum S.K. IL-1 induction of the c-jun promoter. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7054-7058.
63. O'Neill L.A.J. Towards an understanding of the signal transduction pathways for interleukin-1. Biochim. Biophys. Acta 1995, 1266:31-44.
64. Osman M.O., Gesser B., Mortensen J.T., Matsushima K., Jensen S.L., Larsen C.G. Profiles of pro-inflammatory cytokines in the serum of rabbits after experimentally induced acute pancreatitis. Cytokine 2002, 17(1):53-59.
65. Pan M., Stevens B.R. Protein kinase C-dependent regulation of L-arginine transport activity in Caco-2 intestinal cells. Biochim. Biophys. Acta 1995, 1239:27-32.
66. Pan M., Stevens B.R. Differentiation and protein kinase C dependent regulation of alanine transport via system B. J. Biol. Chem. 1995, 270:3582-3587.
67. Prasad S., Mingrino R., Kaukinen K., Hayes K.L., Powell R.M., MacDonald T.T., Collins J.E. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab. Invest. 2005, 85:1139-1162.
68. Rubinstein M., Dinarello C.A., Oppenheim J.J., Hertzog P. Recent advances in cytokines, cytokine receptors and signal transduction. Cytokine Growth Factor Rev. 1998, 9(2):175-181.
69. Sears C., Kaper J. Enteric bacterial toxins: mechanisms of action and link-age to intestinal secretion. Microbiol. Rev. 1996, 60:167-215.
70. Shikhman A.R., Brinson D.C., Lotz M.K. Distinct pathways regulate facilitated glucose transport in human articular chondrocytes during anabolic and catabolic responses. Am. J. Physiol. Endocrinol. Metab. 2004, 286(6):E980-E985.
71. +-glucose transporter expressed in COS-7 cells. Am. J. Physiol. Cell. Physiol. 1999, 276:C1053-C1060.
72. Viñuales C., Gascón S., Barranquero C., Osada J., Rodríguez-Yoldi M.J. Inhibitory effect of IL-1β on galactose intestinal absorption in rabbits. Cell. Physiol. Biochem. 2012, 30:173-186.
73. Weber A., Wasiliew P., Kracht M. Interleukin-1 (IL-1) pathway. Sci. Signal 2010, 3(105):cm1. 10.1126/scisignal.3105cm1.
74. +/glucose cotransporters. J. Exp. Biol. 1997, 200:287-293.
75. Yamashiro O., Morimoto A., Sakata Y., Watanabe T., Murukami N. Febrile and metabolic tolerance to endotoxin and human recombinant interleukin-1 beta in rabbits. Am. J. Physiol. Regul. Integr. Comp. Physiol. 1993, 264:R1180-R1185.
76. Yu L.C., Wang J.T., Wei S.C., Ni Y.H. Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World J. Gastrointest. Pathophysiol. 2012, 3(1):27-43.